US Patent 11779641 Tolerogenic synthetic nanocarriers for allergy therapy
Patent 11779641 was granted and assigned to SELECTA BIOSCIENCES INC on October, 2023 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11779641 Tolerogenic synthetic nanocarriers for allergy therapy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
